Senior Infrastructure & Security Engineer (Temporary) at Vir Biotechnology

San Francisco, California, United States

Vir Biotechnology Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalIndustries

Requirements

  • Minimum 7 years of experience in IT infrastructure and security engineering
  • Strong understanding of SaaS, cloud, and on-premise configuration management
  • Proficiency in scripting languages (e.g., Python, PowerShell) and automation frameworks
  • Experience with network architecture, virtualization, and cloud-native services
  • Familiarity with compliance frameworks and security standards (e.g., CIS Benchmarks, NIST, ISO)
  • Ability to work independently and manage multiple priorities in a fast-paced environment
  • Excellent communication skills and a collaborative approach to cross-functional work
  • Currently authorized to work for any employer in the U.S. (no sponsorship available)
  • Availability for 4 days per week in office at San Francisco headquarters

Responsibilities

  • Perform configuration reviews and hardening assessments across SaaS applications, cloud services, and infrastructure components
  • Identify misconfigurations and gaps in security posture; recommend and implement remediation strategies
  • Maintain and evolve baseline configurations and compliance benchmarks aligned with internal policies and recognized standards
  • Support vulnerability management and incident response efforts with configuration insights and forensic analysis
  • Administer and troubleshoot network components including switches, access points, routers, firewalls, and VPNs
  • Manage virtualized environments and backup systems across hybrid infrastructure
  • Support cloud migration efforts and ensure secure deployment patterns across public cloud platforms
  • Collaborate with development and DevOps teams to ensure secure and scalable infrastructure design
  • Implement and maintain endpoint protection, identity and access controls, and data loss prevention mechanisms
  • Automate security controls and monitoring using scripting and orchestration tools
  • Assist in audit preparation and documentation of security controls and operational procedures

Skills

SaaS
Cloud Infrastructure
On-Premise Systems
Network Administration
Configuration Hardening
Security Assessments
Vulnerability Management
Incident Response
Forensic Analysis

Vir Biotechnology

Develops monoclonal antibodies for infectious diseases

About Vir Biotechnology

Vir Biotechnology develops treatments that leverage the immune system to combat infectious diseases. The company uses a proprietary monoclonal antibody platform combined with machine learning to create a database of human antibodies, which aids in developing effective medicines. Their pipeline includes candidates for hepatitis B, hepatitis delta, HIV, and various viruses like influenza and COVID-19. Vir stands out by collaborating with industry leaders and organizations to accelerate scientific advancements, with the goal of transforming lives through innovative therapies.

San Francisco, CaliforniaHeadquarters
2016Year Founded
$640.6MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Comprehensive healthcare coverage
Employer matched 401(k)
Employee stock purchase plan
Childcare assistance
Tuition reimbursement

Risks

Leadership instability due to key executive resignations may disrupt operations.
Job cuts and facility closures indicate potential financial strain.
Struggles to diversify beyond COVID-19 antibody success may impact revenue growth.

Differentiation

Vir Biotechnology uses AI-enhanced capabilities for monoclonal antibody development.
The company focuses on immune system manipulation for targeted therapies.
Vir's pipeline includes a potential functional cure for chronic hepatitis B.

Upsides

Increased interest in AI-driven drug discovery benefits Vir's AI capabilities.
The rise of personalized medicine aligns with Vir's monoclonal antibody focus.
Global pandemic preparedness funding supports Vir's broad-spectrum antiviral therapies.

Land your dream remote job 3x faster with AI